Compare NYT & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NYT | GMED |
|---|---|---|
| Founded | 1851 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 11.7B |
| IPO Year | N/A | 2012 |
| Metric | NYT | GMED |
|---|---|---|
| Price | $69.33 | $93.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 15 |
| Target Price | $65.33 | ★ $92.42 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 02-04-2026 | 02-19-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | 21.46 | ★ 358.86 |
| EPS | 2.05 | ★ 3.08 |
| Revenue | $2,722,033,000.00 | ★ $2,769,804,000.00 |
| Revenue This Year | $11.06 | $16.86 |
| Revenue Next Year | $6.93 | $8.05 |
| P/E Ratio | $33.82 | ★ $30.29 |
| Revenue Growth | 8.49 | ★ 11.75 |
| 52 Week Low | $44.83 | $51.79 |
| 52 Week High | $71.23 | $94.93 |
| Indicator | NYT | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 60.78 | 69.71 |
| Support Level | $68.69 | $85.65 |
| Resistance Level | $70.52 | $88.71 |
| Average True Range (ATR) | 1.08 | 1.85 |
| MACD | -0.30 | -0.14 |
| Stochastic Oscillator | 60.32 | 95.89 |
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.